Posted by ABMN Staff on Apr 16th, 2024
OncoCyte Co. (NASDAQ:OCX – Get Free Report) CEO Josh Riggs acquired 3,390 shares of OncoCyte stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average price of $2.95 per share, for a total...
More of this article »